Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03489629 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)

Study acronym: STAR-TER
StatusCompleted
PhasePhase 2
Started2018-04-03
View on ClinicalTrials.gov ↗
To evaluate the micro-biologic efficacy and safety of a streamlined treatment for early onset methicillin-resistant staphylococcus aureus (MRSA) in patients with cystic fibrosis.

Amendment history 1 change detected by DataLookout

2026-09-16
notable
Results posted: 2026-09-15
Trial Details
NCT Number NCT03489629
Lead Sponsor University of North Carolina, Chapel Hill
Collaborators: University of Washington, Cook Children's Medical Center, Indiana University, University of Michigan, University of Texas Southwestern Medical Center, St. Louis Children's Hospital
Conditions Cystic Fibrosis
Enrollment 49 participants
Start Date 2018-04-03
Primary Completion 2025-09-30 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-15